3 research outputs found

    Intravenous versus subcutaneous immunoglobulin \u2013 Authors' reply

    No full text
    Reply to comment for Intravenous subcutaneous immunoglobuli

    Intravenous versus subcutaneous immunoglobulin – Authors' reply

    No full text

    Donanemab in early symptomatic Alzheimer disease : the TRAILBLAZER-ALZ 2 randomized clinical trial

    No full text
    corecore